CD47 and liver cancer: Consistent with a previous report in a human liver cancer xenograft model [13], we observed that approximately 6% of the total tumor mass was infiltrated by macrophages when CD47 was blocked by the antibody, whereas only less than 1% was infiltrated in control (Figure 3F').